Cargando…

Monoclonal antibody levels and protection from COVID-19

Multiple monoclonal antibodies have been shown to be effective for both prophylaxis and therapy for SARS-CoV-2 infection. Here we aggregate data from randomized controlled trials assessing the use of monoclonal antibodies (mAb) in preventing symptomatic SARS-CoV-2 infection. We use data on the in vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stadler, Eva, Burgess, Martin T., Schlub, Timothy E., Khan, Shanchita R., Chai, Khai Li, McQuilten, Zoe K., Wood, Erica M., Polizzotto, Mark N., Kent, Stephen J., Cromer, Deborah, Davenport, Miles P., Khoury, David S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382502/ https://www.ncbi.nlm.nih.gov/pubmed/37507368 http://dx.doi.org/10.1038/s41467-023-40204-1

Ejemplares similares

Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2023)

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2022)

How should we use convalescent plasma therapies for the management of COVID-19?
por: Wood, Erica M., et al.
Publicado: (2021)

Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis
por: Chai, Khai Li, et al.
Publicado: (2022)

Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
por: Khoury, David S., et al.
Publicado: (2023)

Population heterogeneity in Plasmodium vivax relapse risk
por: Stadler, Eva, et al.
Publicado: (2022)

Anticoagulation in COVID-19
por: Bradbury, Charlotte A, et al.
Publicado: (2022)

HIV-1 Mutation and Recombination Rates Are Different in Macrophages and T-cells
por: Cromer, Deborah, et al.
Publicado: (2016)

Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk
por: Kiely, Philip, et al.
Publicado: (2017)

Erratum to “Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk” (Transfusion Medicine Reviews 31/3 [2017] 154-164)
por: Kiely, Philip, et al.
Publicado: (2018)

The TREATT Trial (TRial to EvaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial
por: Estcourt, Lise J., et al.
Publicado: (2019)

Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?
por: Kent, Stephen J., et al.
Publicado: (2022)

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
por: Cromer, Deborah, et al.
Publicado: (2021)

Evidence for exposure dependent carriage of malaria parasites across the dry season: modelling analysis of longitudinal data
por: Stadler, Eva, et al.
Publicado: (2023)

Platelet storage duration and its clinical and transfusion outcomes: a systematic review
por: Aubron, Cécile, et al.
Publicado: (2018)

Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants
por: Reynaldi, Arnold, et al.
Publicado: (2019)

A Description of the Type, Frequency and Severity of Infections Among Sixteen Patients Treated for T-Cell Lymphoma
por: Ko, Tina, et al.
Publicado: (2021)

Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma
por: Ratnasingam, Sumita, et al.
Publicado: (2019)

The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
por: Koutsakos, Marios, et al.
Publicado: (2022)

Reduced erythrocyte susceptibility and increased host clearance of young parasites slows Plasmodium growth in a murine model of severe malaria
por: Khoury, David S., et al.
Publicado: (2015)

Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
por: Khoury, David S., et al.
Publicado: (2020)

Predicting CD62L expression during the CD8+ T cell response in vivo
por: Schlub, Timothy E., et al.
Publicado: (2009)

Where Have All the Parasites Gone? Modelling Early Malaria Parasite Sequestration Dynamics
por: Cromer, Deborah, et al.
Publicado: (2013)

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
por: Lee, Wen Shi, et al.
Publicado: (2023)

Accurately Measuring Recombination between Closely Related HIV-1 Genomes
por: Schlub, Timothy E., et al.
Publicado: (2010)

Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma
por: Dendle, Claire, et al.
Publicado: (2017)

Tissue-Type Plasminogen Activator and Tenecteplase-Mediated Increase in Blood Brain Barrier Permeability Involves Cell Intrinsic Complement
por: Keragala, Charithani B., et al.
Publicado: (2020)

Current and future strategies to monitor and manage coagulation in ECMO patients
por: Zeibi Shirejini, Saeedreza, et al.
Publicado: (2023)

Definitions of massive transfusion in adults with critical bleeding: a systematic review
por: Lin, Victor S., et al.
Publicado: (2023)

Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
por: McQuilten, Zoe, et al.
Publicado: (2022)

Modeling the dynamics of neonatal CD8+ T cell responses
por: Reynaldi, Arnold, et al.
Publicado: (2016)

A general method to eliminate laboratory induced recombinants during massive, parallel sequencing of cDNA library
por: Waugh, Caryll, et al.
Publicado: (2015)

Preferential selection of viral escape mutants by CD8(+) T cell ‘sieving’ of SIV reactivation from latency
por: Docken, Steffen S., et al.
Publicado: (2023)

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
por: Wheatley, Adam K., et al.
Publicado: (2021)

Cryopreserved platelets compared with liquid-stored platelets for the treatment of surgical bleeding: protocol for two multicentre randomised controlled blinded non-inferiority trials (the CLIP-II and CLIPNZ-II trials)
por: Reade, Michael C., et al.
Publicado: (2022)

Human monoclonal antibodies and monoclonal antibody multispecificity.
por: Campbell, A. M., et al.
Publicado: (1987)

Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry
por: Bergin, Krystal, et al.
Publicado: (2016)

Validation of multiplex PCR sequencing assay of SIV
por: Moriarty, Ryan V., et al.
Publicado: (2021)

Cryoprecipitate transfusion in trauma patients attenuates hyperfibrinolysis and restores normal clot structure and stability: Results from a laboratory sub-study of the FEISTY trial
por: Morrow, Gael B., et al.
Publicado: (2022)

Is platelet transfusion associated with hospital-acquired infections in critically ill patients?
por: Aubron, Cécile, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1mvor2g76lvck8e7npdh19t6d5